AzTrials
AzTrials

Plantar Fasciitis of Both FeetGood FeetNCT07103070

A Test of Efficacy and Foot Position Alteration in Patients Wearing Good Feet Arch Supports for the Treatment of Pain

An observational study of Plantar Fasciitis of Both Feet and Metatarsalgia, run by Massachusetts General Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is a single armed prospective case series designed to evaluate the efficacy of treating common structural-related foot ailments (i.e. plantar fasciitis, metatarsalgia, and/or hallux valgus) with a high quality non-custom made arch support. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Arch supports
Type of treatment
Medical device
How many people
43 participants
Where
1 siteUnited States
Study dates
13 Jun 2022to 31 Mar 2024
How long will I take part?
12 Weeks
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Subjects will be recruited from the clinicians in the Division of Podiatry under the Department of Orthopaedics. Additionally, the sponsor, Good Feet Worldwide has a trade store the MGH service area, and will allow us to promote the study at their location with an advertisement poster. Potential subjects from the trade store will be referred to our clinics for screening and, when appropriate, recruited for the study.

Who may be able to join

  • Men or women ≥ 18 and ≤ 65 years of age
  • Able and willing to comply with study procedures, and a signed and dated
  • Diagnosed with symptomatic hallux valgus and/or plantar fasciitis and/or metatarsalgia
  • Has had foot pain for at least 30 days
  • Willing and able to utilize insole when walking for 90 days
  • BMI ≤ 35
  • Able to walk up to 0.5 miles without difficulty in a 24-hour period

Who cannot join

  • Inability or unwillingness to comply with study procedures
  • Gross asymmetry in feet, where shoe size differs by 2 or more full sizes between right and left foot
  • Subject has had a CT performed within the last 30 days, for any body part.
  • Prior partial or total amputation of a foot
  • BMI > 35.
  • Unilateral or bilateral foot deformity that would hinder the fitting of an over-the-counter arch support, such as active Charcot foot or Charcot with boney prominence
Show all 11Show fewer
  • Ulcers or open sores on either foot
  • Currently wearing custom shoes or insoles.
  • Currently ambulating with a cane, crutches, walker.
  • Currently using any type of foot or ankle brace, and/or having used a brace in the last 30 days.
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Massachusetts General Hospital

    Boston, Massachusetts, 02114

Other trials in United States

About this study

This study is a single armed prospective case series designed to evaluate the efficacy of treating common structural-related foot ailments (i.e. plantar fasciitis, metatarsalgia, and/or hallux valgus) with a high quality non-custom made arch support. It is believed that these conditions are the result of inadequate or poorly fitted arch supports resulting in a lack of structural correction in the foot while weight bearing. Over-the-counter insoles are believed to counteract the shortcomings in foot structure that result in these painful conditions. In this study, it is proposed that changes in foot morphology can be measured quantitatively using weight bearing CT Scan (Computerized Tomography) and X-rays of the subject with and without the arch supports. Subjects will also answer questions from a validated series of questionnaires pertaining to their foot condition and generalized health and activity level.

The study is a minimal risk study, with all subjects receiving the arch supports being investigated. There is no placebo offered. Initial evaluation of all subjects will include all imaging and measurements. Collection of subjective responses will occur after 4 weeks, 8 weeks, and 12 weeks of treatment.

Read the detailed description
  1. Background and Significance Foot orthoses are arch supports that can be worn in the shoes, and are designed to relieve pain by providing support to various areas of the foot to eliminate or reduce excessive mechanical forces. Most commonly, these devices are used as part of the treatment protocol for a variety of common foot ailments including painful plantar fasciitis and pronation. A variety of musculoskeletal pains have been shown to be reduced, and stability in ambulation can be improved by adding arch support to the shoes. Most importantly, previous studies have demonstrated that the structure of the foot can be altered, and with that the function of the foot, when orthoses are used. Previous studies have demonstrated multiple biomechanical and clinical benefits of using foot orthoses and arch supports. These devices have been shown to alter foot positioning and forefoot pressure during walking, reducing heel and forefoot pressures, decreasing impact forces, and improving comfort. Cadaveric studies confirm that orthoses enhance ankle and subtalar joint stability, correct abnormal rotations, improve arch alignment, and increase arch height under simulated load. Clinical studies involving military personnel found that wearing arch supports significantly reduced stress fracture incidence and improved comfort. Additionally, arch supports were associated with decreased lower back pain after prolonged use. Research also indicated that orthotic devices reduce tibial internal rotation, influencing the mechanical function of proximal structures like the ankle and leg. Furthermore, orthoses positively impacted foot deformities, pain (foot, knee, hip, and back), and balance, as demonstrated by radiographic and center-of-pressure analyses, indicating overall improvements in stability and symptomatic relief. The goal of the current study is to investigate the clinical and biomechanical effects of arch-support insoles in common foot pathologies including plantar fasciitis, and metatarsalgia.
  2. Specific Aims and Objectives The objective of this study is to measure the structural changes that occur in the foot when wearing arch supports, and how these changes correlate with overall relief of common structural-related foot ailments; plantar fasciitis, metatarsalgia, and/or hallux valgus Specific Aim #1: Measure any changes that occur in the position and alignment of the foot bones relative to one another using weight bearing radiographs and weight bearing CT scans, with and without over-the-counter arch supports under the sole of the feet. Hypothesis: Arch supports (orthoses) will alter the positioning and alignment of the bones of the foot when standing. Any changes will be measurable in three dimensions, using both weight bearing CT scans and standard anterior-posterior and lateral radiographs. Specific Aim #2: Demonstrate if there is a correlation between symptomatic relief of painful foot conditions including plantar fasciitis and metatarsalgia pain using validated clinical scores and quality of life measures. Hypothesis: Painful foot conditions will improve when subjects wear over-the-counter arch supports on a regular basis, as demonstrated by validated subjective scoring.
  3. General Description of Study Design

This study is a single armed prospective case series designed to evaluate the efficacy of treating common structural-related foot ailments (i.e. plantar fasciitis, metatarsalgia, and/or hallux valgus) with a high quality non-custom made arch support. It is believed that these conditions are the result of inadequate or poorly fitted arch supports resulting in a lack of structural correction in the foot while weight bearing. Over-the-counter insoles are believed to counteract the shortcomings in foot structure that result in these painful conditions. In this study, it is proposed that changes in foot morphology can be measured quantitatively using weight bearing CT Scan (Computerized Tomography) and X-rays of the subject with and without the arch supports. Subjects will also answer questions from a validated series of questionnaires pertaining to their foot condition and generalized health and activity level.

The study is a minimal risk study, with all subjects receiving the arch supports being investigated. There is no placebo offered. Initial evaluation of all subjects will include all imaging and measurements. Collection of subjective responses will occur after 4 weeks, 8 weeks, and 12 weeks of treatment.

Subject Recruitment:

Subjects will be recruited from the clinicians in the Division of Podiatry under the Department of Orthopaedics. Additionally, the sponsor, Good Feet Worldwide has a trade store the MGH service area, and will allow us to promote the study at their location with an advertisement poster. Potential subjects from the trade store will be referred to our clinics for screening and, when appropriate, recruited for the study.

Potential subjects will contact the principal investigator, Dr. Adam Landsman for preliminary screening and if they are able to satisfy the basic criteria, will be invited for formal screening. If qualified, they will be enrolled to begin the study. In order to avoid any undue pressure, all potential subjects who are patients of one of the Investigators will be given the option to do any or all of the following:

  • Offer patients the opportunity to take home the Consent Form, and call back if they wish to participate
  • Offer to connect the patient with other health care providers to discuss participation.

All study subjects will be screened and evaluated at the Foot and Ankle Clinic at MGH Waltham. Screenings and enrollments will take place on Tuesdays and Wednesdays, during dedicated research time.

The conditions being examined here are common among all races and genders, and enrollment is open to all. There have been limitations placed on subject age, as this age group is most likely to experience the conditions being studied.

Being tested
Arch supports
Keywords
arch supports, heel pain, metatarsalgia, plantar fasciitis
Medical subject headings
Metatarsalgia, Morton Neuroma, Low Back Pain, Fasciitis, Plantar

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Arch supportsDevice

    Set of 3 arch supports supplied by Good Feet

Study groups in NCT07103070
Study groupRoleWhat they receive
Inclusion 1. Men or women ≥ 18 and ≤ 65 years of age 2. The subject is able and willing to comply wSubjects with foot pain who are able to wear arch supports.
Receives: Device: Arch supports

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient Reported Outcome Measurement Information System (PROMIS)-Pain Intensity Score

    Change in symptoms and relief of pain will be quantified based on subjective completion of validated questionnaires. Scoring is based on a 5-point scale, with higher scores indicating greater pain intensity. Raw scores are converted to T-scores, standardized to a mean of 50 (average for the general population) and a standard deviation of 10. Higher T-scores reflect more severe pain intensity.

    Measured: 12 weeks

  2. Patient Reported Outcome Measurement Information System (PROMIS)-Pain Interference Score

    PROMIS Pain Interference measures the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities. Respondents rate how much pain has interfered with their daily life over the past 7 days. Scoring uses a 5-point scale, with higher scores indicating greater interference. Raw scores are converted to T-scores (mean = 50, SD = 10); higher T-scores represent more significant pain interference.

    Measured: 12 weeks

Secondary outcomes (3)
  1. Change in foot morphology- Weightbearing X-ray

    Foot alignment will be assessed using linear and angular measurements on anteroposterior and lateral views of plain radiographs. Images will be taken at baseline with and without insoles

    Measured: Baseline

  2. Change in foot morphology- Weightbearing CT scans

    Foot alignment will be assessed using 3D, linear, and angular measurements on CT scans. Images will be taken at baseline with and without insoles

    Measured: Baseline

  3. Patient Reported Outcome Measurement Information System (PROMIS)-Global Health

    PROMIS Global Health is a brief patient-reported outcome measure that assesses general physical, mental, and social health. It includes items covering overall health, quality of life, physical health, mental health, social roles, and symptom burden. Scoring is based on responses to a set of items (typically 4 or 10), each using a 5-point scale. Raw scores are converted to T-scores (mean = 50, SD = 10), with higher T-scores indicating better global health status.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2025
  2. Study start13 Jun 2022
  3. Primary completion31 Dec 2023
  4. Study completion31 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
43 participants (actual)
Target duration
12 Weeks
IDs, dates and publications
ClinicalTrials.gov ID
NCT07103070
Sponsor's protocol ID
2022P000291
Acronym
Good Feet
Status last verified
Aug 2025
First submitted
14 Jul 2025
Last updated
8 Aug 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: HIPPA compliance

Questions about this trial

What is this clinical trial studying?

An observational study of Plantar Fasciitis of Both Feet and Metatarsalgia, run by Massachusetts General Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient Reported Outcome Measurement Information System (PROMIS)-Pain Intensity Score (time frame: 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in